331 related articles for article (PubMed ID: 14688356)
1. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
Nefedova Y; Huang M; Kusmartsev S; Bhattacharya R; Cheng P; Salup R; Jove R; Gabrilovich D
J Immunol; 2004 Jan; 172(1):464-74. PubMed ID: 14688356
[TBL] [Abstract][Full Text] [Related]
2. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
Nefedova Y; Nagaraj S; Rosenbauer A; Muro-Cacho C; Sebti SM; Gabrilovich DI
Cancer Res; 2005 Oct; 65(20):9525-35. PubMed ID: 16230418
[TBL] [Abstract][Full Text] [Related]
3. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.
Nefedova Y; Cheng P; Gilkes D; Blaskovich M; Beg AA; Sebti SM; Gabrilovich DI
J Immunol; 2005 Oct; 175(7):4338-46. PubMed ID: 16177074
[TBL] [Abstract][Full Text] [Related]
4. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
[TBL] [Abstract][Full Text] [Related]
5. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
6. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
7. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
[TBL] [Abstract][Full Text] [Related]
9. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
10. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
12. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
[TBL] [Abstract][Full Text] [Related]
13. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice.
Hackenmiller R; Kim J; Feldman RA; Simon MC
Immunity; 2000 Sep; 13(3):397-407. PubMed ID: 11021537
[TBL] [Abstract][Full Text] [Related]
14. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
Chaturvedi P; Reddy MV; Reddy EP
Oncogene; 1998 Apr; 16(13):1749-58. PubMed ID: 9582023
[TBL] [Abstract][Full Text] [Related]
15. [H2O2-induced activation of transcription factors STAT1 and STAT3: the role of EGF receptor and tyrosine kinase JAK2].
Burova EB; Grudinkin PS; Bardin AA; Gamaleĭ NN
Tsitologiia; 2001; 43(12):1153-61. PubMed ID: 11881154
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
17. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
19. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
20. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
